These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 26133084)

  • 1. Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain.
    Hanafy AS; Farid RM; ElGamal SS
    Drug Dev Ind Pharm; 2015; 41(12):2055-68. PubMed ID: 26133084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer's disease management.
    Hanafy AS; Farid RM; Helmy MW; ElGamal SS
    Drug Deliv; 2016 Oct; 23(8):3111-3122. PubMed ID: 26942549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
    Fazil M; Md S; Haque S; Kumar M; Baboota S; Sahni JK; Ali J
    Eur J Pharm Sci; 2012 Aug; 47(1):6-15. PubMed ID: 22561106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.
    Wang X; Chi N; Tang X
    Eur J Pharm Biopharm; 2008 Nov; 70(3):735-40. PubMed ID: 18684400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.
    Saini D; Fazil M; Ali MM; Baboota S; Ali J
    Drug Deliv; 2015; 22(6):823-36. PubMed ID: 24725026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
    Rukmangathen R; Yallamalli IM; Yalavarthi PR
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
    [No Abstract]   [Full Text] [Related]  

  • 8. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
    Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
    Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer's disease in intracerebroventricular streptozotocin model for brain delivery.
    Zameer S; Ali J; Vohora D; Najmi AK; Akhtar M
    J Drug Target; 2021 Feb; 29(2):199-216. PubMed ID: 32876502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification and Brain Targeting of Eugenol-Loaded Surface Modified Nanoparticles Through Intranasal Route in the Treatment of Cerebral Ischemia.
    Ahmad N; Ahmad R; Alam MA; Ahmad FJ
    Drug Res (Stuttg); 2018 Oct; 68(10):584-595. PubMed ID: 29669380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease.
    Muntimadugu E; Dhommati R; Jain A; Challa VG; Shaheen M; Khan W
    Eur J Pharm Sci; 2016 Sep; 92():224-34. PubMed ID: 27185298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal galantamine/chitosan complex nanoparticles elicit neuroprotection potentials in rat brains via antioxidant effect.
    Kandil LS; Farid RM; ElGamal SS; Hanafy AS
    Drug Dev Ind Pharm; 2021 May; 47(5):735-740. PubMed ID: 34032549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal Piperine-Loaded Chitosan Nanoparticles as Brain-Targeted Therapy in Alzheimer's Disease: Optimization, Biological Efficacy, and Potential Toxicity.
    Elnaggar YS; Etman SM; Abdelmonsif DA; Abdallah OY
    J Pharm Sci; 2015 Oct; 104(10):3544-56. PubMed ID: 26147711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
    Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
    Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain delivery of buspirone hydrochloride chitosan nanoparticles for the treatment of general anxiety disorder.
    Bari NK; Fazil M; Hassan MQ; Haider MR; Gaba B; Narang JK; Baboota S; Ali J
    Int J Biol Macromol; 2015 Nov; 81():49-59. PubMed ID: 26210037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.
    Patil GB; Surana SJ
    J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
    Md S; Khan RA; Mustafa G; Chuttani K; Baboota S; Sahni JK; Ali J
    Eur J Pharm Sci; 2013 Feb; 48(3):393-405. PubMed ID: 23266466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foot and Mouth Disease virus-loaded fungal chitosan nanoparticles for intranasal administration: impact of formulation on physicochemical and immunological characteristics.
    Tajdini F; Amini MA; Mokarram AR; Taghizadeh M; Azimi SM
    Pharm Dev Technol; 2014 May; 19(3):333-41. PubMed ID: 23590209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of insulin chitosan-nanoparticles loaded in buccal films.
    Al-Nemrawi NK; Alsharif SSM; Alzoubi KH; Alkhatib RQ
    Pharm Dev Technol; 2019 Oct; 24(8):967-974. PubMed ID: 31092092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of Cerebral Ischemia.
    Ahmad N; Ahmad R; Naqvi AA; Alam MA; Ashafaq M; Samim M; Iqbal Z; Ahmad FJ
    Int J Biol Macromol; 2016 Oct; 91():640-55. PubMed ID: 27264648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.